Trial NCT00199381

View at ClinicalTrials.gov 
Org. Study IDs: 6002-US-025

Last trial update was posted on 2013-11-21

MeSH Interventions

Istradefylline

MeSH Conditions

Parkinson Disease

Other Conditions

Parkinson's Disease

Stopping Reasons

Additional long-term safety data no longer needed

Limitations And Caveats

The Sponsor decided to terminate the study early (not for safety reasons); as a result 323 subjects discontinued early. Mean duration of therapy was 18.7 months (0.4 to 31.4 months); median duration was 21.0 months. Total exposure 767 subject years.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID